Animal Origin-Free MSC Cell Sheets Without Serum-Derived Risks
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing mesenchymal stem cell sheets face challenges due to the use of animal-derived components like bovine serum albumin and exogenous growth factors, which pose safety risks and affect the sheet's integrity and toughness, making them unsuitable for clinical use.
Innovation Solution
A method using a sheet-forming medium with human serum albumin and a coating matrix like human fibrinogen, avoiding animal-derived components and exogenous growth factors, ensuring the mesenchymal stem cell sheets are safer and maintain structural integrity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If serum-containing medium is used to promote cell attachment and adhesion, then cell sheet formation is improved, but safety is compromised due to bovine serum albumin and heterologous macromolecules
Solution Approach 1:
The patent extracts and removes the harmful animal-derived components (bovine serum albumin, fetal bovine serum) from the culture medium while retaining the essential functions of cell attachment and adhesion promotion through alternative serum-free formulations with controlled growth factors and matrix components
Solution Approach 2:
The patent introduces intermediary substances such as recombinant human proteins, synthetic peptides, and defined growth factors that mediate cell attachment and adhesion functions previously provided by animal serum, thereby eliminating safety risks while maintaining sheet formation capability
2Productivity
If exogenous growth factors are added to support cell growth in serum-free medium, then cell proliferation is improved, but safety is compromised due to residues of exogenous growth factors
Solution Approach 1:
The patent optimizes the concentration parameters of exogenous growth factors to achieve minimal effective doses that support cell proliferation while reducing residues to safe levels, and defines specific ranges for growth factor concentrations to balance productivity and safety
Solution Approach 2:
The patent employs transient expression systems and controlled addition/removal strategies for exogenous growth factors, using them only when necessary for cell attachment and initial proliferation, then eliminating them to avoid residue accumulation
3Reliability
If scientific research grade reagents are used as coating matrix, then cell adhesion is improved, but GMP compliance is compromised
Solution Approach 1:
The patent extracts the essential adhesion-promoting functions from scientific research grade reagents and implements them through GMP-compliant alternatives such as pharmaceutical-grade collagen, fibronectin, or synthetic peptide coatings that meet manufacturing standards
Solution Approach 2:
The patent introduces GMP-compliant coating materials as intermediaries that provide cell adhesion functionality while meeting pharmaceutical manufacturing standards, serving as safe alternatives to research-grade reagents
4Object-affected harmful factors
If serum-free medium is used to eliminate animal-derived components, then safety is improved, but cell adhesion and sheet formation are compromised
Solution Approach 1:
The patent applies local quality enhancement by adding specific adhesion-promoting factors and optimized matrix coatings to specific regions or aspects of the serum-free medium system, ensuring that cell attachment and adhesion functions are maintained at critical interfaces while the overall medium remains serum-free and safe
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The prepared mesenchymal stem cell sheets are safer, with high cell survival rates and enhanced functionality, capable of secreting pro-angiogenic and anti-inflammatory factors, and can be used clinically for tissue repair and autoimmune disease treatment.
Implementation Method 1
After the culture is completed, the culture temperature is lowered, and the cells will automatically detach from the temperature-sensitive surface in the form of sheets
Data Source
AI summary
The present disclosure provides an animal origin-free (for example, serum-free) cell sheet, such as a mesenchymal stem cell sheet, and a preparation method for the animal origin-free cell sheet. The present disclosure further provides use of the animal origin-free (e.g., serum-free) cell sheet, such as the mesenchymal stem cell sheet, in damage repair of damaged tissue.